FI901755A0 - Menetelmä terapeuttisesti aktiivisten hydroksialkyylifuranyylijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten hydroksialkyylifuranyylijohdannaisten valmistamiseksi

Info

Publication number
FI901755A0
FI901755A0 FI901755A FI901755A FI901755A0 FI 901755 A0 FI901755 A0 FI 901755A0 FI 901755 A FI901755 A FI 901755A FI 901755 A FI901755 A FI 901755A FI 901755 A0 FI901755 A0 FI 901755A0
Authority
FI
Finland
Prior art keywords
6alkyl
hydrogen
derivatives
arylc1
alk
Prior art date
Application number
FI901755A
Other languages
English (en)
Swedish (sv)
Other versions
FI95702B (fi
FI95702C (fi
Inventor
Frans Eduard Janssens
Gaston Stanislas Marcell Diels
Joseph Elisabeth Leenaerts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI901755A0 publication Critical patent/FI901755A0/fi
Publication of FI95702B publication Critical patent/FI95702B/fi
Application granted granted Critical
Publication of FI95702C publication Critical patent/FI95702C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI901755A 1989-04-07 1990-04-06 Menetelmä terapeuttisesti aktiivisten hydroksialkyylifuranyylijohdannaisten valmistamiseksi FI95702C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33502289A 1989-04-07 1989-04-07
US33502289 1989-04-07

Publications (3)

Publication Number Publication Date
FI901755A0 true FI901755A0 (fi) 1990-04-06
FI95702B FI95702B (fi) 1995-11-30
FI95702C FI95702C (fi) 1996-03-11

Family

ID=23309914

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901755A FI95702C (fi) 1989-04-07 1990-04-06 Menetelmä terapeuttisesti aktiivisten hydroksialkyylifuranyylijohdannaisten valmistamiseksi

Country Status (21)

Country Link
EP (1) EP0393738B1 (fi)
JP (1) JPH02290874A (fi)
KR (1) KR900016193A (fi)
CN (1) CN1031403C (fi)
AT (1) ATE114653T1 (fi)
AU (1) AU615612B2 (fi)
CA (1) CA2013892A1 (fi)
DE (1) DE69014385T2 (fi)
DK (1) DK0393738T3 (fi)
ES (1) ES2067645T3 (fi)
FI (1) FI95702C (fi)
GR (1) GR3015154T3 (fi)
HU (1) HUT58324A (fi)
IE (1) IE65460B1 (fi)
IL (1) IL94008A (fi)
NO (1) NO174851C (fi)
NZ (1) NZ233088A (fi)
PH (1) PH30434A (fi)
PT (1) PT93671B (fi)
RU (1) RU2030415C1 (fi)
ZA (1) ZA902664B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2043564A1 (en) * 1990-07-06 1992-01-07 Alfons G. M. De Knaep 3-[(5-methyl-2-furanyl)methyl]-n-(4-piperidinyl)-3h-imidazo [4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
FR2668150B1 (fr) * 1990-10-17 1994-11-18 Theramex Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
DK0599968T3 (da) * 1991-08-14 2000-04-17 Procter & Gamble Pharma Oxazolidinonderivater, der er egnede som antiarytmi- og antifibrilleringsmidler
WO1993014088A1 (en) * 1992-01-09 1993-07-22 Janssen Pharmaceutica N.V. Antihistaminic piperazinyl derivatives
US5521183A (en) * 1994-08-30 1996-05-28 Allergan Use of 5-HT ligands as anti-pruritic agents
ID29268A (id) 1998-12-19 2001-08-16 Janssen Pharmaceutica Nv Senyawa spiro yang bersifat antihistamin
AP1552A (en) 1999-06-28 2006-01-17 Janssen Pharmaceutica Nv Respiratory syncytial virus replication inhibitors.
WO2016100823A1 (en) 2014-12-19 2016-06-23 The Broad Institute, Inc. Dopamine d2 receptor ligands
EP3233077A4 (en) 2014-12-19 2018-08-08 The Broad Institute Inc. Dopamine d2 receptor ligands

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4588722A (en) * 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
GB8515934D0 (en) * 1985-06-24 1985-07-24 Janssen Pharmaceutica Nv (4-piperidinomethyl and-hetero)purines
EP0232937B1 (en) * 1986-02-03 1992-08-19 Janssen Pharmaceutica N.V. Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines

Also Published As

Publication number Publication date
GR3015154T3 (en) 1995-05-31
AU5295190A (en) 1990-10-11
NO174851B (no) 1994-04-11
JPH02290874A (ja) 1990-11-30
PT93671A (pt) 1990-11-20
PT93671B (pt) 1996-06-28
DE69014385T2 (de) 1995-04-20
PH30434A (en) 1997-05-09
ES2067645T3 (es) 1995-04-01
CN1046161A (zh) 1990-10-17
RU2030415C1 (ru) 1995-03-10
NO901580L (no) 1990-10-08
FI95702B (fi) 1995-11-30
EP0393738B1 (en) 1994-11-30
IE65460B1 (en) 1995-11-01
NZ233088A (en) 1991-10-25
CA2013892A1 (en) 1990-10-07
NO174851C (no) 1994-07-20
FI95702C (fi) 1996-03-11
ATE114653T1 (de) 1994-12-15
IE901257L (en) 1990-10-07
KR900016193A (ko) 1990-11-12
IL94008A (en) 1997-02-18
AU615612B2 (en) 1991-10-03
DE69014385D1 (de) 1995-01-12
HUT58324A (en) 1992-02-28
CN1031403C (zh) 1996-03-27
DK0393738T3 (da) 1995-01-16
HU902107D0 (en) 1990-07-28
NO901580D0 (no) 1990-04-06
IL94008A0 (en) 1991-01-31
EP0393738A1 (en) 1990-10-24
ZA902664B (en) 1991-12-24

Similar Documents

Publication Publication Date Title
NO883069L (no) 2-(heterocyklylalkyl)imidazopyridiner.
GR3005715T3 (fi)
FI900084A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsol-2-yyli- ja imidatso/4,5-b/pyridin-2-yyli-amino- ja -metyyli-1-piperidinyylietyylijohdannaisten valmistamiseksi
FI901755A0 (fi) Menetelmä terapeuttisesti aktiivisten hydroksialkyylifuranyylijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: JANSSEN PHARMACEUTICA N.V.